<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/64BC5E73-972F-41E1-A12C-D97DC9BDFB93"><gtr:id>64BC5E73-972F-41E1-A12C-D97DC9BDFB93</gtr:id><gtr:name>MRC Clinical Sciences Centre</gtr:name><gtr:address><gtr:line1>Faculty of Medicine Imperial College</gtr:line1><gtr:line2>London Hammersmith Campus</gtr:line2><gtr:line3>Du Cane Road</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>W12 0NN</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/64BC5E73-972F-41E1-A12C-D97DC9BDFB93"><gtr:id>64BC5E73-972F-41E1-A12C-D97DC9BDFB93</gtr:id><gtr:name>MRC Clinical Sciences Centre</gtr:name><gtr:address><gtr:line1>Faculty of Medicine Imperial College</gtr:line1><gtr:line2>London Hammersmith Campus</gtr:line2><gtr:line3>Du Cane Road</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>W12 0NN</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/126192C0-C75D-45A6-A222-01C6419441C0"><gtr:id>126192C0-C75D-45A6-A222-01C6419441C0</gtr:id><gtr:firstName>Anne</gtr:firstName><gtr:otherNames>Katherine</gtr:otherNames><gtr:surname>Soutar</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U120074271"><gtr:id>CA950EF5-3905-4D77-8526-412B27AFD35F</gtr:id><gtr:title>Lipoprotein</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U120074271</gtr:grantReference><gtr:abstractText>Inherited defects in the uptake of lipoproteins, or cholesterol-carrying complexes, by the liver cause hypercholesterolaemia, where so-called bad cholesterol accumulates in the blood to high levels. This in turn leads to increased risk of heart disease. The most common and well-studied disorder is caused by defects in the gene for a protein called the LDL-receptor, which specifically recognises these lipoproteins and allows them to be taken up by the liver for disposal. These defects are relatively common (1/500 individuals carry a copy of the defective gene) and constitute a major risk factor for early coronary heart disease. Although most individuals with inherited hypercholesterolaemia have mutations in genes known to play a part in this process, the defect remains unknown in others. We are attempting to understand why some newly-identified defects in genes cause hypercholesterolaemia. We investigate the function of the proteins these genes encode in cultured cells from both affected patients and unaffected individuals. Understanding the mechanisms involved will shed light on the complex way in which the LDL receptor is trafficked between different parts of a cell so that it can function correctly. This may also reveal other candidate genes in which defects may cause hypercholesterolaemia. Clinically, knowledge of the inherited defect allows early identification of affected relatives so preventative measures can be taken, and understanding the underlying mechanisms may suggest new targets for lipid-lowering drug therapy.</gtr:abstractText><gtr:technicalSummary>Disorders in the genetic regulation of human lipoprotein metabolism Objectives: 1. To elucidate the role of the LDL-receptor specific clathrin adaptor ARH and SNX17 in endocytosis, intracellular trafficking and sorting of the LDL receptor, and to investigate other potential roles for ARH in regulation of cell proliferation. 2. To determine how gain-of-function mutations in the novel proprotein convertase PCSK9 cause dominantly inherited hypercholesterolaemia using a transgenic model. 3. To characterise novel genetic and metabolic defects in patients with inherited disorders of lipoprotein metabolism due to unknown causes. Investigations will be based on the expression in cultured cells of mutant and chimaeric forms of the various proteins involved. Their effects on receptor-mediated endocytosis and trafficking of receptor proteins, and on their co-localisation with other key components of different subcellular compartments will be observed. Pathways known to be involved in regulation of cell proliferation will be investigated in cultured cells from subjects with ARH deficiency. Lipoprotein metabolism will be investigated in tissues and cells expressing a BAC encoding wild type or mutant gain-of-function human PCSK9. In order to identify patients with novel defects, defects in known genes are first sought by DNA sequencing, and the results reported to my clinical collaborator and used for diagnostic purposes. Novel defects will be investigated initially by analysis of LDL receptor function and lipoprotein uptake in patients cells and by sequencing potential candidate genes.</gtr:technicalSummary><gtr:fund><gtr:end>2012-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1993-10-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>2917047</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visit London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>FF95D530-B287-40B4-808C-6CED8D79FFC3</gtr:id><gtr:impact>presentation to approx. 30 AS and A level students at school Biology Society

No formal impact</gtr:impact><gtr:outcomeId>FHimNvnn8w4</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>161940</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF project grant</gtr:description><gtr:end>2007-10-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>54B74957-B868-41D5-8600-422B3B07C917</gtr:id><gtr:outcomeId>VxRyBpQTTP60</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Identification of FH</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:guidelineTitle>Identification and management of familial hypercholesterolaemiaa</gtr:guidelineTitle><gtr:id>E93F5EA2-6241-4B52-9202-B95CC4C422BB</gtr:id><gtr:impact>Will increase diagnosis of FH and allow treatment to prevent early heart disease http://publications.nice.org.uk/identification-and-management-of-familial-hypercholesterolaemia-cg71</gtr:impact><gtr:outcomeId>B9212E85AFD</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type><gtr:url>http://www.nice.org.uk/CG71</gtr:url></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>Development of mutation screening and detection methods for DNA-based diagnosis of familial hypercholesterolaemia (FH), and contributed to pilot studies for national cascade screening</gtr:description><gtr:id>0C0B1324-22D6-46D6-AEDA-C22E09118F2A</gtr:id><gtr:impact>Cascade screening for FH now recommended by NICE.</gtr:impact><gtr:outcomeId>CDF2CEDC9E8</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>On hold</gtr:status><gtr:title>DNA based diagnosis</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2010</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Mice expressing human normal or gain-of-function mutant PCSK9 under physiological control. Useful as model for human atherosclerosis.</gtr:description><gtr:id>7FB25CB3-6E82-4C39-8C3D-8C79E32676B5</gtr:id><gtr:impact>too early to assess</gtr:impact><gtr:outcomeId>TUWe6jEeWiy</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>PCSK9 transgenic mice</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>943B44A6-2C41-49D5-948F-390603080FBD</gtr:id><gtr:title>Premature senescence in cells from patients with autosomal recessive hypercholesterolemia (ARH): evidence for a role for ARH in mitosis.</gtr:title><gtr:parentPublicationTitle>Arteriosclerosis, thrombosis, and vascular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d6b5b320fef2f1f45ba3a8b56ca0de7"><gtr:id>4d6b5b320fef2f1f45ba3a8b56ca0de7</gtr:id><gtr:otherNames>Sun XM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1079-5642</gtr:issn><gtr:outcomeId>f3HtqGCuiAr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D73EAABC-4285-45D1-8A17-6D333BB86E7B</gtr:id><gtr:title>A rare polymorphism in the low density lipoprotein (LDL) gene that affects mRNA splicing.</gtr:title><gtr:parentPublicationTitle>Atherosclerosis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9d1224aa035ceb1ac4b32932cb57474"><gtr:id>d9d1224aa035ceb1ac4b32932cb57474</gtr:id><gtr:otherNames>Bourbon M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9150</gtr:issn><gtr:outcomeId>362F28A2BC7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2C7DB6F-329A-495E-ADEC-CFA93D633BAC</gtr:id><gtr:title>Genetic diagnosis of familial hypercholesterolaemia: a mutation and a rare non-pathogenic amino acid variant in the same family.</gtr:title><gtr:parentPublicationTitle>Atherosclerosis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ee620a604796cefbdadcdc07ad0ab1a"><gtr:id>2ee620a604796cefbdadcdc07ad0ab1a</gtr:id><gtr:otherNames>Naoumova RP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0021-9150</gtr:issn><gtr:outcomeId>pm_15935_15_15135252</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FCCD2AF1-7898-4CEE-805B-16CC38F69333</gtr:id><gtr:title>Adaptor protein disabled-2 modulates low density lipoprotein receptor synthesis in fibroblasts from patients with autosomal recessive hypercholesterolaemia.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fbf0d9c02c865c4031d09d9c36940bef"><gtr:id>fbf0d9c02c865c4031d09d9c36940bef</gtr:id><gtr:otherNames>Eden ER</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>13A28D7BEF3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80D8D6B9-9AED-4EE2-A71C-5D1AA2660FD7</gtr:id><gtr:title>Two novel missense mutations in ABCA1 result in altered trafficking and cause severe autosomal recessive HDL deficiency.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fbdc4aada47f930d898c5741e8800aff"><gtr:id>fbdc4aada47f930d898c5741e8800aff</gtr:id><gtr:otherNames>Albrecht C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>pm_15935_15_15158913</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDF1A44D-2363-42E5-87DB-9F75A6409FE0</gtr:id><gtr:title>Restoration of LDL receptor function in cells from patients with autosomal recessive hypercholesterolemia by retroviral expression of ARH1.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fbf0d9c02c865c4031d09d9c36940bef"><gtr:id>fbf0d9c02c865c4031d09d9c36940bef</gtr:id><gtr:otherNames>Eden ER</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>pm_15935_15_12464675</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2AFE53F-EEC0-48E3-804B-5D8890616F78</gtr:id><gtr:title>Mechanisms of disease: genetic causes of familial hypercholesterolemia.</gtr:title><gtr:parentPublicationTitle>Nature clinical practice. Cardiovascular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa57d899081b536cc3efbe5c3021e769"><gtr:id>aa57d899081b536cc3efbe5c3021e769</gtr:id><gtr:otherNames>Soutar AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1743-4297</gtr:issn><gtr:outcomeId>D8BA54FFCD1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B1BE4CE-696F-41BB-B4BB-337A302425FD</gtr:id><gtr:title>Familial hypercholesterolaemia in Portugal.</gtr:title><gtr:parentPublicationTitle>Atherosclerosis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9d1224aa035ceb1ac4b32932cb57474"><gtr:id>d9d1224aa035ceb1ac4b32932cb57474</gtr:id><gtr:otherNames>Bourbon M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9150</gtr:issn><gtr:outcomeId>B658A9B4C76</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>360577E4-FD67-4C08-A2C1-75F4F2042B42</gtr:id><gtr:title>Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia.</gtr:title><gtr:parentPublicationTitle>Atherosclerosis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50ee780b203e8438daa14062e300e9bb"><gtr:id>50ee780b203e8438daa14062e300e9bb</gtr:id><gtr:otherNames>Pisciotta L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9150</gtr:issn><gtr:outcomeId>8470216FB8A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5002C77-715F-4D08-8F1D-19C65466F08B</gtr:id><gtr:title>In&amp;nbsp;vitro functional characterization of missense mutations in the LDLR gene.</gtr:title><gtr:parentPublicationTitle>Atherosclerosis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d01dee248a9f4609e223c78290f848ca"><gtr:id>d01dee248a9f4609e223c78290f848ca</gtr:id><gtr:otherNames>Silva S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9150</gtr:issn><gtr:outcomeId>pm_15935_25_23021490</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>097A2351-836E-4117-BF2B-67BB20DC7ECB</gtr:id><gtr:title>Rare genetic causes of autosomal dominant or recessive hypercholesterolaemia.</gtr:title><gtr:parentPublicationTitle>IUBMB life</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa57d899081b536cc3efbe5c3021e769"><gtr:id>aa57d899081b536cc3efbe5c3021e769</gtr:id><gtr:otherNames>Soutar AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1521-6543</gtr:issn><gtr:outcomeId>pm_15935_25_20073037</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>923B4F67-770B-4527-9CFD-BAD6690ABB70</gtr:id><gtr:title>Identification and biochemical analysis of a novel APOB mutation that causes autosomal dominant hypercholesterolemia.</gtr:title><gtr:parentPublicationTitle>Molecular genetics &amp; genomic medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/43aba469a8d4344115b82265d11aee32"><gtr:id>43aba469a8d4344115b82265d11aee32</gtr:id><gtr:otherNames>Thomas ER</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2324-9269</gtr:issn><gtr:outcomeId>doi_15935_02_mgg3_17</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E890B193-678F-4E2D-911C-EEE3CED6B5F3</gtr:id><gtr:title>Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/558935b8ec585676e1fbc52231a67b82"><gtr:id>558935b8ec585676e1fbc52231a67b82</gtr:id><gtr:otherNames>Humphries SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>0222BB571CE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAD60B6C-8957-4029-A7E4-7ED7A059C9C1</gtr:id><gtr:title>The transmembrane domain and PXXP motifs of ApoE receptor 2 exclude it from carrying out clathrin-mediated endocytosis.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d6b5b320fef2f1f45ba3a8b56ca0de7"><gtr:id>4d6b5b320fef2f1f45ba3a8b56ca0de7</gtr:id><gtr:otherNames>Sun XM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_15935_15_12621059</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E613FC4-0AB9-465C-B378-A5169E39A929</gtr:id><gtr:title>The use of next-generation sequencing in clinical diagnosis of familial hypercholesterolemia.</gtr:title><gtr:parentPublicationTitle>Genetics in medicine : official journal of the American College of Medical Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/737a3b1b4bbcc2863da782c70d702de5"><gtr:id>737a3b1b4bbcc2863da782c70d702de5</gtr:id><gtr:otherNames>Vandrovcova J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1098-3600</gtr:issn><gtr:outcomeId>pm_15935_25_23680767</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20437233-4177-4E16-93FD-72DD048AF74A</gtr:id><gtr:title>Genetic diagnosis of familial hypercholesterolaemia: the importance of functional analysis of potential splice-site mutations.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9d1224aa035ceb1ac4b32932cb57474"><gtr:id>d9d1224aa035ceb1ac4b32932cb57474</gtr:id><gtr:otherNames>Bourbon M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>104B329CE40</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2789FE72-301B-4B10-887E-FB5700E100BD</gtr:id><gtr:title>Autosomal recessive hypercholesterolaemia: long-term follow up and response to treatment.</gtr:title><gtr:parentPublicationTitle>Atherosclerosis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ee620a604796cefbdadcdc07ad0ab1a"><gtr:id>2ee620a604796cefbdadcdc07ad0ab1a</gtr:id><gtr:otherNames>Naoumova RP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0021-9150</gtr:issn><gtr:outcomeId>pm_15935_15_15135266</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13C695EB-F7B2-4675-A355-DD5CB5452671</gtr:id><gtr:title>Genetic defects causing familial hypercholesterolaemia: identification of deletions and duplications in the LDL-receptor gene and summary of all mutations found in patients attending the Hammersmith Hospital Lipid Clinic.</gtr:title><gtr:parentPublicationTitle>Atherosclerosis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95ad0a779db599af82d62a69d310a7f3"><gtr:id>95ad0a779db599af82d62a69d310a7f3</gtr:id><gtr:otherNames>Tosi I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9150</gtr:issn><gtr:outcomeId>900DE654D94</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3FB608DA-DD22-4063-B888-095263DD0583</gtr:id><gtr:title>Degradation of LDLR protein mediated by 'gain of function' PCSK9 mutants in normal and ARH cells.</gtr:title><gtr:parentPublicationTitle>Atherosclerosis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a172499c8e5e2e904a71bc5d2629cb2"><gtr:id>0a172499c8e5e2e904a71bc5d2629cb2</gtr:id><gtr:otherNames>Fasano T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9150</gtr:issn><gtr:outcomeId>26BC5CC2AC7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98D65A35-3080-46CF-B1FD-A5C473457BE8</gtr:id><gtr:title>Current management of severe homozygous hypercholesterolaemias.</gtr:title><gtr:parentPublicationTitle>Current opinion in lipidology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ee620a604796cefbdadcdc07ad0ab1a"><gtr:id>2ee620a604796cefbdadcdc07ad0ab1a</gtr:id><gtr:otherNames>Naoumova RP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0957-9672</gtr:issn><gtr:outcomeId>pm_15935_15_15243214</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC696D17-33DA-4245-A3A3-E4070981E22C</gtr:id><gtr:title>Severe hypercholesterolemia in four British families with the D374Y mutation in the PCSK9 gene: long-term follow-up and treatment response.</gtr:title><gtr:parentPublicationTitle>Arteriosclerosis, thrombosis, and vascular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ee620a604796cefbdadcdc07ad0ab1a"><gtr:id>2ee620a604796cefbdadcdc07ad0ab1a</gtr:id><gtr:otherNames>Naoumova RP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1079-5642</gtr:issn><gtr:outcomeId>pm_15935_15_16224054</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9859ADDC-0F4E-402F-9BA0-35B5252FEF7F</gtr:id><gtr:title>Evidence for effect of mutant PCSK9 on apolipoprotein B secretion as the cause of unusually severe dominant hypercholesterolaemia.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d6b5b320fef2f1f45ba3a8b56ca0de7"><gtr:id>4d6b5b320fef2f1f45ba3a8b56ca0de7</gtr:id><gtr:otherNames>Sun XM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_15935_15_15772090</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>643A8AF6-65CD-4824-A841-6B5BEB03B044</gtr:id><gtr:title>Genetics, clinical phenotype, and molecular cell biology of autosomal recessive hypercholesterolemia.</gtr:title><gtr:parentPublicationTitle>Arteriosclerosis, thrombosis, and vascular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa57d899081b536cc3efbe5c3021e769"><gtr:id>aa57d899081b536cc3efbe5c3021e769</gtr:id><gtr:otherNames>Soutar AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>1079-5642</gtr:issn><gtr:outcomeId>pm_15935_15_12958046</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>927DDBE9-A7AD-49AA-8429-E3F95957A10C</gtr:id><gtr:title>Sorting motifs in the intracellular domain of the low density lipoprotein receptor interact with a novel domain of sorting nexin-17.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/794777f2d36ee6730f5db7b161647627"><gtr:id>794777f2d36ee6730f5db7b161647627</gtr:id><gtr:otherNames>Burden JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_15935_15_14739284</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>891FFE76-5417-4FCC-BB81-DA4C1A3B04D7</gtr:id><gtr:title>Increased secretion of lipoproteins in transgenic mice expressing human D374Y PCSK9 under physiological genetic control.</gtr:title><gtr:parentPublicationTitle>Arteriosclerosis, thrombosis, and vascular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8620def2c61b03369fd607a56f8693b6"><gtr:id>8620def2c61b03369fd607a56f8693b6</gtr:id><gtr:otherNames>Herbert B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1079-5642</gtr:issn><gtr:outcomeId>HPtwTMWgycq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ACDD5736-BDE9-4EA7-BCAE-E222FA3A9968</gtr:id><gtr:title>A single point mutation in the low-density lipoprotein receptor switches the degradation of its mature protein from the proteasome to the lysosome.</gtr:title><gtr:parentPublicationTitle>The international journal of biochemistry &amp; cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4c07d7a1d6837d0201659d1df6a462d"><gtr:id>c4c07d7a1d6837d0201659d1df6a462d</gtr:id><gtr:otherNames>Mart?n de Llano JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1357-2725</gtr:issn><gtr:outcomeId>01BDF7B1E02</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30A85AD2-1B24-4E2D-89FB-AC63061C335E</gtr:id><gtr:title>Autosomal recessive hypercholesterolemia.</gtr:title><gtr:parentPublicationTitle>Seminars in vascular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa57d899081b536cc3efbe5c3021e769"><gtr:id>aa57d899081b536cc3efbe5c3021e769</gtr:id><gtr:otherNames>Soutar AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1528-9648</gtr:issn><gtr:outcomeId>pm_15935_15_15630633</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>450AEE1D-014A-48BD-94C4-1963D0B7A106</gtr:id><gtr:title>Effects of ezetimibe and/or simvastatin on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase gene expression: a randomized trial in healthy men.</gtr:title><gtr:parentPublicationTitle>Atherosclerosis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32459a8d682a6799cc209a7143dd294f"><gtr:id>32459a8d682a6799cc209a7143dd294f</gtr:id><gtr:otherNames>Gouni-Berthold I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9150</gtr:issn><gtr:outcomeId>49B308F5D41</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3937B57D-4F79-4D9E-B3D7-23A147FA828E</gtr:id><gtr:title>Unexpected roles for PCSK9 in lipid metabolism.</gtr:title><gtr:parentPublicationTitle>Current opinion in lipidology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa57d899081b536cc3efbe5c3021e769"><gtr:id>aa57d899081b536cc3efbe5c3021e769</gtr:id><gtr:otherNames>Soutar AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0957-9672</gtr:issn><gtr:outcomeId>pm_15935_25_21494143</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U120074271</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>12A0B409-0C29-4056-9092-2D86E44017F3</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.4  Methodologies and measurements</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>